Kiniksa Pharmaceuticals, Ltd. (KNSA)
NASDAQ·Healthcare·Biotechnology
$53.86
+23.49%
Mkt Cap $3.18B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$58.33
Range $55.00 – $62.00
Implied Upside
+8.3%
Consensus $58.33 vs current $53.86
NASDAQ·Healthcare·Biotechnology
$53.86
+23.49%
Mkt Cap $3.18B
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$58.33
Range $55.00 – $62.00
+8.3%
Consensus $58.33 vs current $53.86